Founding father recognised for outstanding cancer care
15 November 2017
A founding father of Melanoma Institute Australia, Professor William McCarthy AM, has been recognised for his contributions to cancer care by being awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care at the Clinical Oncology Society of Australia dinner last night.
The award is given annually to a national leader who has made a significant contribution over a long period of time to cancer care through research, clinical leadership and community service.
One nominee wrote: “There is no questioning Professor McCarthy’s contribution to the improvement of the care of patients with cancer and in particular patients with melanoma in his home state of New South Wales, in Australia and internationally…. in the roles of clinician, researcher, teacher and contributor to national forums related to the disease.”
The former Executive Director of the Sydney Melanoma Unit (now known as Melanoma Institute Australia) has led the world in melanoma education, general medical education and melanoma surgery.
Professor McCarthy graduated from The University of Sydney’s Faculty of Medicine in 1958 and trained in surgery at St Vincent’s Hospital Sydney. He then obtained a Master’s Degree in Medical Education at the University of Illinois, Chicago, and worked in various surgical registrar postings in the United Kingdom.
Returning to Sydney in 1968, Professor McCarthy was appointed a Lecturer in Surgery at The University of Sydney and a Visiting Medical Officer at Sydney Hospital where he worked with Professor Gerry Milton in the Sydney Melanoma Unit.
His academic achievements include some 180 peer‐reviewed publications over a span of 50 years. He was promoted steadily in the University, becoming Professor of Surgery (Melanoma and Skin Oncology) in 1990; a post he held until his retirement in 2005 when he was appointed Professor Emeritus.
His contributions were recognised by appointment as a Member (AM) of the Order of Australia in 1993 and receipt of the World Health Organisation Melanoma Award in 2001. He served on the Clinical Oncology Society of Australia Council and was President in 1992 and 1993.
Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.